I. Hoffmeister

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib

L. Hertle, E. Herrmann, S. Bierer, 2011, World Journal of Urology.

Combined Immunochemotherapy in Selected Patients With Metastatic Renal Cell Carcinoma: HLA Class II Genotype Can Help to Predict Response to Therapy

J. Gerss, L. Hertle, R. Kelsch, 2011, Journal of immunotherapy.